India Prohibits 35 Fixed - Dose Combination Drugs: A Critical Move Towards Safer Medication In a landmark decision to enhance patient safety, India’s top drug regulator—the Central Drugs Standard Control Organization (CDSCO)—has ordered a ban on the manufacture and sale of 35 fixed-dose combination (FDC) medicines. These include widely used drugs such as pain relievers, nutrit...

Read More